All Stories

  1. NIFTP revised: Chronicle of a change foretold
  2. Nodular fasciitis of the parotid gland: A challenging diagnosis on FNA
  3. The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC): An international effort toward improved patient care-when the roots might be inspired by Leonardo da Vinci
  4. Ancillary molecular testing of indeterminate thyroid nodules
  5. Impact on clinical follow-up of the Milan System for salivary gland cytology: A comparison with a traditional diagnostic classification
  6. Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules
  7. The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration
  8. “Suspicious” salivary gland FNA: Risk of malignancy and interinstitutional variability
  9. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features in the pediatric age group
  10. “Atypical” salivary gland fine needle aspiration: Risk of malignancy and interinstitutional variability
  11. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): Implications for the risk of malignancy (ROM) in the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC)
  12. Incidence, malignancy rates of diagnoses and cyto-histological correlations in the new Italian Reporting System for Thyroid Cytology: An institutional experience
  13. The Milan System for Reporting Salivary Gland Cytopathology: Analysis and suggestions of initial survey
  14. The role of thyroid FNA cytology in pediatric malignant lesions: An overview of the literature
  15. Young investigator challenge: The morphologic analysis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on liquid-based cytology: Some insights into their identification
  16. Morphological features that can predictBRAFV600E-mutated carcinoma in paediatric thyroid cytology
  17. The impact of FNAC in the management of salivary gland lesions: Institutional experiences leading to a risk-based classification scheme
  18. The cytological diagnosis of a ‘benign thyroid lesion’: is it a real safe diagnosis for the patient?
  19. UncommonBRAFmutations in the follicular variant of thyroid papillary carcinoma: New insights
  20. Thyroid FNA: International perspectives from the European Congress of Cytopathology-Can we cross the bridge of classifications?
  21. The role of liquid-based cytology and ancillary techniques in pleural and pericardic effusions: An institutional experience
  22. The potential of liquid-based cytology in lymph node cytological evaluation: the role of morphology and the aid of ancillary techniques
  23. Is thyroid gland only a “land” for primary malignancies? role of morphology and immunocytochemistry
  24. Morphological parameters able to predictBRAFV600E-mutated malignancies on thyroid fine-needle aspiration cytology: Our institutional experience
  25. Large non-functioning parathyroid cysts: our institutional experience of a rare entity and a possible pitfall in thyroid cytology
  26. Analysis of immunocytochemical and molecular BRAF expression in thyroid carcinomas: A cytohistologic institutional experience
  27. Who was responsible for reaching the Americas—Columbus or his ships?: Focusing on the side of liquid‐based cytology: The importance and role of the cytopathologist as opposed to the cytological method used
  28. Papillary thyroid microcarcinoma: a painstaking category to manage
  29. The role of thyroid fine‐needle aspiration cytology in the pediatric population: An institutional experience
  30. The cytologic category of oncocytic (Hurthle) cell neoplasm mostly includes low-risk lesions at histology: an institutional experience
  31. Diagnostic and prognostic value of immunocytochemistry and BRAF mutation analysis on liquid-based biopsies of thyroid neoplasms suspicious for carcinoma